53 related articles for article (PubMed ID: 3654182)
1. N-CAM in cerebrospinal fluid: a marker of synaptic remodelling after acute phases of multiple sclerosis?
Massaro AR; Albrechtsen M; Bock E
Ital J Neurol Sci; 1987 Jun; Suppl 6():85-8. PubMed ID: 3654182
[TBL] [Abstract][Full Text] [Related]
2. The neural cell adhesion molecule (NCAM) present in the cerebrospinal fluid of multiple sclerosis patients is unsialylated.
Massaro AR; De Pascalis D; Carnevale A; Carbone G
Eur Rev Med Pharmacol Sci; 2009; 13(5):397-9. PubMed ID: 19961048
[TBL] [Abstract][Full Text] [Related]
3. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
[TBL] [Abstract][Full Text] [Related]
4. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis.
Chowdhury SA; Lin J; Sadiq SA
Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193
[TBL] [Abstract][Full Text] [Related]
5. Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis.
Kawajiri M; Mogi M; Osoegawa M; Matsuoka T; Tsukuda K; Kohara K; Horiuchi M; Miki T; Kira JI
Mult Scler; 2008 May; 14(4):557-60. PubMed ID: 18562510
[TBL] [Abstract][Full Text] [Related]
6. Endothelin and nitric oxide levels in cerebrospinal fluid of patients with multiple sclerosis.
Speciale L; Sarasella M; Ruzzante S; Caputo D; Mancuso R; Calvo MG; Guerini FR; Ferrante P
J Neurovirol; 2000 May; 6 Suppl 2():S62-6. PubMed ID: 10871788
[TBL] [Abstract][Full Text] [Related]
7. Tau protein, phosphorylated tau protein and beta-amyloid42 in the cerebrospinal fluid of multiple sclerosis patients.
Valis M; Talab R; Stourac P; Andrys C; Masopust J
Neuro Endocrinol Lett; 2008 Dec; 29(6):971-6. PubMed ID: 19112391
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha and its soluble receptors in plasma and cerebrospinal fluid of multiple sclerosis patients treated with methylprednisolone.
Franciotta D; Bergamaschi R; Martino G; Zardini E; Desina G; Cosi V
Eur Cytokine Netw; 1999 Sep; 10(3):431-6. PubMed ID: 10477400
[TBL] [Abstract][Full Text] [Related]
9. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity.
Dore-Duffy P; Newman W; Balabanov R; Lisak RP; Mainolfi E; Rothlein R; Peterson M
Ann Neurol; 1995 Jan; 37(1):55-62. PubMed ID: 7529475
[TBL] [Abstract][Full Text] [Related]
10. Soluble adhesion molecules (sVCAM-1 and sICAM-1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosis.
Rieckmann P; Altenhofen B; Riegel A; Baudewig J; Felgenhauer K
Ann Neurol; 1997 Mar; 41(3):326-33. PubMed ID: 9066353
[TBL] [Abstract][Full Text] [Related]
11. [Neurofilament protein light in multiple sclerosis].
Zhang Y; Li X; Qiao J
Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
[TBL] [Abstract][Full Text] [Related]
12. Adhesion molecule expression on cerebrospinal fluid T lymphocytes: evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls.
Svenningsson A; Hansson GK; Andersen O; Andersson R; Patarroyo M; Stemme S
Ann Neurol; 1993 Aug; 34(2):155-61. PubMed ID: 8338339
[TBL] [Abstract][Full Text] [Related]
13. Tetranectin in cerebrospinal fluid of patients with multiple sclerosis.
Stoevring B; Jaliashvili I; Thougaard AV; Ensinger C; Høgdall CK; Rasmussen LS; Sellebjerg F; Christiansen M
Scand J Clin Lab Invest; 2006; 66(7):577-83. PubMed ID: 17101549
[TBL] [Abstract][Full Text] [Related]
14. Nuclear magnetic resonance study of cerebrospinal fluid from patients with multiple sclerosis.
Lynch J; Peeling J; Auty A; Sutherland GR
Can J Neurol Sci; 1993 Aug; 20(3):194-8. PubMed ID: 8221382
[TBL] [Abstract][Full Text] [Related]
15. (alpha)B-crystallin in cerebrospinal fluid of patients with multiple sclerosis.
Stoevring B; Vang O; Christiansen M
Clin Chim Acta; 2005 Jun; 356(1-2):95-101. PubMed ID: 15878466
[TBL] [Abstract][Full Text] [Related]
16. Detection of myelin basic protein in cerebrospinal fluid.
Ohta M; Ohta K
Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid total tau protein levels in patients with multiple sclerosis.
Terzi M; Birinci A; Cetinkaya E; Onar MK
Acta Neurol Scand; 2007 May; 115(5):325-30. PubMed ID: 17489943
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide as an activity marker in multiple sclerosis.
Acar G; Idiman F; Idiman E; Kirkali G; Cakmakçi H; Ozakbaş S
J Neurol; 2003 May; 250(5):588-92. PubMed ID: 12736739
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis.
Kawajiri M; Mogi M; Higaki N; Matsuoka T; Ohyagi Y; Tsukuda K; Kohara K; Horiuchi M; Miki T; Kira JI
Mult Scler; 2009 Feb; 15(2):262-5. PubMed ID: 19136547
[TBL] [Abstract][Full Text] [Related]
20. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
